Dermatomyositis

Galectin-9 reflects the interferon signature and correlates with disease activity in systemic autoimmune diseases. Response to: ‘Biomarkers: to be or not to be’ by Yavuz and Rönnblom
Lucas L van den Hoogen, Eefje H M van der Heijden, Maarten R Hillen, Jorre S Mertens, Ruth D E Fritsch-Stork, Timothy R D J Radstake, Joel A G van Roon

Annals of the Rheumatic Diseases Jan 2020, 79 (1) e9; DOI: 10.1136/annrheumdis-2018-214651
First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort
Masatoshi Jinnin, Akiko Ohta, Shoichiro Ishihara, Hirofumi Amano, Tatsuya Atsumi, Manabu Fujimoto, Takashi Kanda, Yasushi Kawaguchi, Atsushi Kawakami, Akio Mimori, Tsuneyo Mimori, Toshihide Mimura, Yoshinao Muro, Hajime Sano, Jun Shimizu, Tsutomu Takeuchi, Yoshiya Tanaka, Kazuhiko Yamamoto, Takayuki Sumida, Hitoshi Kohsaka

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-215488; DOI: 10.1136/annrheumdis-2019-215488
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216248; DOI: 10.1136/annrheumdis-2019-216248
Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216246; DOI: 10.1136/annrheumdis-2019-216246
Association of anti-Ro52 autoantibodies with interstitial lung disease in connective tissue diseases
Si Wu, Xiaojun Tang, Liping Wu, Liang-jing Lu, Xuebing Feng

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216372; DOI: 10.1136/annrheumdis-2019-216372
The heart of anti-Ku related disease: extensive review and meta-analysis. Response to: ‘Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis’ by Campochiaro et al
Lionel Spielmann, François Séverac, Alain Meyer

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-216095; DOI: 10.1136/annrheumdis-2019-216095
Correspondence to ‘Standardisation of myositis-specific antibodies: where are we today?’ by Mahler et al
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro

Annals of the Rheumatic Diseases Sep 2019, annrheumdis-2019-216217; DOI: 10.1136/annrheumdis-2019-216217
Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria
Martin Greco, María Jesus García de Yébenes, Inmaculada Alarcón, Anahy María Brandy-García, Íñigo Rúa-Figueroa, Estibaliz Loza, Loreto Carmona

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1291-1292; DOI: 10.1136/annrheumdis-2019-215031
Standardisation of myositis-specific antibodies: where are we today?
Michael Mahler, Jean-Baptiste Vulsteke, Xavier Bossuyt, Ellen De Langhe, Minoru Satoh

Annals of the Rheumatic Diseases Aug 2019, annrheumdis-2019-216003; DOI: 10.1136/annrheumdis-2019-216003
Artificial intelligence should always be guided by human intelligence. Response to ‘Augmented vs. artificial intelligence for stratification of patients with myositis’ by Mahler et al
Alain Meyer, Lionel Spielmann, François Séverac

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-216014; DOI: 10.1136/annrheumdis-2019-216014

Main menu

Dermatomyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dermatomyositis

Pages